We aimed to deliver a cancer Ag peptide to XCR1+ DCs with high cross-presenting activity, by using a fusion protein, XCL1-OT-I, to carry the OT-I peptide and a chemokine, XCL1. The gene discussed is XCR1; the disease is cancer.